University of Michigan: Minorities Saw Steeper Drop in Access to Opioid Use Disorder Meds During Pandemic
June 16, 2022
June 16, 2022
ANN ARBOR, Michigan, June 16 (TNSjou) -- The University of Michigan issued the following news release:
Relative to white patients, racial and ethnic groups saw a sharper decline in access to medicines to treat opioid use disorder during the early stages of the COVID-19 pandemic--intensifying pre-pandemic disparities, says a University of Michigan researcher.
"We found that COVID-19 was associated with widened racial and ethnic disparities in buprenorphine, the most . . .
Relative to white patients, racial and ethnic groups saw a sharper decline in access to medicines to treat opioid use disorder during the early stages of the COVID-19 pandemic--intensifying pre-pandemic disparities, says a University of Michigan researcher.
"We found that COVID-19 was associated with widened racial and ethnic disparities in buprenorphine, the most . . .